Transcriptome-scale target biology and AI-driven automated chemistry produced a validated lead candidate in weeks, against an ...

Unlike the human brain, which has tens of billions of neurons, the fly brain has fewer than 200,000. Despite its relative ...

Founded by serial entrepreneur and CEO, Yann Fleureau, and former AI research leader at Novartis and Owkin Eric Durand, ...

Available online at chairsidemagazine.com and mailing to more than 100,000 dental practitioners nationwide, the free clinical ...

Dignify Therapeutics ("Dignify", the "Company"), a biopharmaceutical development company focused on restoring bowel and ...

(Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the ...

Multi-project collaboration with Fred Hutch Cancer Center spans biomarker discovery in bladder cancer and a single cell ...

Novartis announced today that the U.S. Food and Drug Administration (FDA) approved Rhapsido ® (remibrutinib), an oral, highly ...

Preclinical package also shows more than 2.5-fold survival extension in advanced PDAC models; Company contrasts a non-RAS, ...

Biohub, the U.S. Department of Energy, the National Institutes of Health, and new funding partners today announced a major ...

Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary ...

The Mark Foundation for Cancer Research today announced its latest Endeavor Award recipients, providing a total of $12 ...